Decrease of the electroacupuncture-induced analgesic effects in nuclear factor-kappa B1 knockout mice.

Hi-Joon Park; Hyang-Sook Lee; Hye-Jung Lee; Yeong-Min Yoo; Hee Jae Lee; Soon Ae Kim; Kanghyun Leem; Ho-Chul Kim; Jung-Chul Seo; Ee-Hwa Kim; Sabina Lim; Joo-Ho Chung

doi:10.1016/s0304-3940(01)02582-4

PubMed · 11834313

Decrease of the electroacupuncture-induced analgesic effects in nuclear factor-kappa B1 knockout mice.

Hi-Joon Park·Hyang-Sook Lee·Hye-Jung Lee·Yeong-Min Yoo·Hee Jae Lee·Soon Ae Kim·Kanghyun Leem·Ho-Chul Kim·Jung-Chul Seo·Ee-Hwa Kim·Sabina Lim·Joo-Ho Chung

View original source ↗Export metadata ↓

Abstract

To investigate the involvement of nuclear factor kappa B1 (NF-kappaB1; p50/p105) in electroacupuncture (EA)-induced analgesia, 2 and 100 Hz EA stimulations were applied at acupoint ST36 (Zusanli) in NF-kappaB1 knockout mice. EA was performed for 30 min and tail-flick latencies (TFLs) were evaluated every 15 min for 1 h. Wild-type mice displayed a 63.3% increase in TFLs compared to baseline after 2 Hz EA, whereas NF-kappaB1+/- mice exhibited a 41.8% increase and NF-kappaB1-/- mice showed only a 3.9% increase of TFLs. The TFLs of 100 Hz EA showed similar trends: a 72.6% increase of TFLs in wild-type, a 38.6% increase in NF-kappaB1+/- and a 9.3% increase in NF-kappaB1-/- mice. The present findings suggest that NF-kappaB1 may play a crucial role in both low and high frequency EA-induced analgesic effects.

Explore related subjects

Analgesia Animals Electroacupuncture Female Male Mice Mice, Knockout NF-kappa B Pain Pain Measurement Protein Isoforms Reaction Time Tail Journal Article Research Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Hi-Joon Park, Hyang-Sook Lee, Hye-Jung Lee, Yeong-Min Yoo, Hee Jae Lee, Soon Ae Kim, Kanghyun Leem, Ho-Chul Kim, Jung-Chul Seo, Ee-Hwa Kim, Sabina Lim, Joo-Ho Chung. 2002-02-22. Decrease of the electroacupuncture-induced analgesic effects in nuclear factor-kappa B1 knockout mice.. https://doi.org/10.1016/s0304-3940(01)02582-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Sex differences in drug- and non-drug-induced analgesia.

Historically, biomedical research has been conducted almost exclusively with male subjects. A growing number of studies now demonstrate sex differences in analgesia produced both by drugs and by environmental stimuli. This review summarizes the current literature on sex differences in analgesia produced by opioids, cholinergics and other drugs, and by stress, exercise and other environmental manipulations. A brief overview of the physiological mechanisms underlying sex differences in analgesia is provided, as well as suggestions for future research. It is not yet known whether the development of sex-specific analgesia treatment guidelines is warranted.

Analgesia↗

PubMed2003

Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.

The blood-brain barrier restricts the passage of substances into the brain. Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier. Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain. Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake. In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacological effect. We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin. We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the observed antinociceptive effect of dalargin. These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.

Analgesia↗

PubMed2003

Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice.

The influence of morphine dosing time on analgesic effect after acute or chronic treatment, recovery of analgesic effect after once developed tolerance, and their pharmacological mechanisms were investigated in ICR male mice under a 12-h light/dark cycle (light on from 7:00 AM to 7:00 PM). There was a significant 24-h rhythm in the latency of thermal response at 30 min after morphine injection. The analgesic effect was significantly greater at the dark phase than at the light phase. The rhythmic pattern resembled overall the rhythm occurring in the latency of thermal response under non-drugged state. The absolute value of morphine analgesic effect (the real time spent on the hot-plate) on days 1 and 2 after morphine daily injection was significantly larger after morphine injection at 9:00 PM than after saline injection at 9:00 PM or after morphine injection at 9:00 AM. The recovery from tolerance of analgesic effect was significantly faster at the dark phase than at the light phase. The time-dependent difference in the analgesic effect after chronic treatment or recovery from tolerance is closely related to that in the expression of mu-opioid receptor. The present study suggests that 24-h rhythm of morphine analgesic effect is consistent with 24-h rhythm of mu-opioid receptor expression.

Analgesia↗